Photobiomodulation with near infrared light mitigates Alzheimer's disease-related pathology in cerebral cortex - Evidence from two transgenic mouse models

Alzheimer's Research and Therapy

Volumn 6, Issue 1, 2014, Pages

  Purushothuman, Sivaraman ^a   Johnstone, Daniel M ^a   Nandasena, Charith ^a   Mitrofanis, John ^a   Stone, Jonathan ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84894244452     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/alzrt232     Document Type: Article

References (50)

1. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Hardy J, Selkoe DJ, Science 2002 297 353 356 10.1126/science.1072994 12130773 (Pubitemid 34790756)
2. Staging of Alzheimer's disease-related neurofibrillary changes. Braak H, Braak E, Neurobiol Aging 1995 16 271 278 10.1016/0197-4580(95)00021-6 7566337
3. Oxidative damage is the earliest event in Alzheimer disease. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA, J Neuropathol Exp Neurol 2001 60 759 767 11487050 (Pubitemid 32678256)
4. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD, Proc Natl Acad Sci USA 2009 106 14670 14675 10.1073/pnas.0903563106 19667196
5. What initiates the formation of senile plaques? The origin of Alzheimer-like dementias in capillary haemorrhages. Stone J, Med Hypotheses 2008 71 347 359 10.1016/j.mehy.2008.04.007 18524497
6. Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes. Calabrese V, Guagliano E, Sapienza M, Panebianco M, Calafato S, Puleo E, Pennisi G, Mancuso C, Butterfield DA, Stella AG, Neurochem Res 2007 32 757 773 10.1007/s11064-006-9203-y 17191135 (Pubitemid 46481305)
7. Effect of NASA light-emitting diode irradiation on wound healing. Whelan HT, Smits RL Jr, Buchman EV, Whelan NT, Turner SG, Margolis DA, Cevenini V, Stinson H, Ignatius R, Martin T, Martin T, Cwiklinski J, Philippi AF, Graf WR, Hodgson B, Gould L, Kane M, Chen G, Caviness J, J Clin Laser Med Surg 2001 19 305 314 10.1089/104454701753342758 11776448 (Pubitemid 33131406)
8. Clinical and experimental applications of NIR-LED photobiomodulation. Desmet KD, Paz DA, Corry JJ, Eells JT, Wong-Riley MT, Henry MM, Buchmann EV, Connelly MP, Dovi JV, Liang HL, Henshel DS, Yeager RL, Millsap DS, Lim J, Gould LJ, Das R, Jett M, Hodgson BD, Margolis D, Whelan HT, Photomed Laser Surg 2006 24 121 128 10.1089/pho.2006.24.121 16706690 (Pubitemid 43837144)
9. Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy. Eells JT, Wong-Riley MT, VerHoeve J, Henry M, Buchman EV, Kane MP, Gould LJ, Das R, Jett M, Hodgson BD, Margolis D, Whelan HT, Mitochondrion 2004 4 559 567 10.1016/j.mito.2004.07.033 16120414 (Pubitemid 39646806)
10. Gene and noncoding RNA regulation underlying photoreceptor protection: microarray study of dietary antioxidant saffron and photobiomodulation in rat retina. Natoli R, Zhu Y, Valter K, Bisti S, Eells J, Stone J, Mol Vis 2010 16 1801 1822 20844572
11. Transcranial low-level laser therapy improves neurological performance in traumatic brain injury in mice: effect of treatment repetition regimen. Xuan W, Vatansever F, Huang L, Wu Q, Xuan Y, Dai T, Ando T, Xu T, Huang YY, Hamblin MR, PLoS One 2013 8 53454 10.1371/journal.pone.0053454 23308226
12. Low-level laser therapy applied transcranially to mice following traumatic brain injury significantly reduces long-term neurological deficits. Oron A, Oron U, Streeter J, de Taboada L, Alexandrovich A, Trembovler V, Shohami E, J Neurotrauma 2007 24 651 656 10.1089/neu.2006.0198 17439348 (Pubitemid 46996025)
13. Photobiomodulation preserves behaviour and midbrain dopaminergic cells from MPTP toxicity: evidence from two mouse strains. Moro C, Torres N, El Massri N, Ratel D, Johnstone DM, Stone J, Mitrofanis J, Benabid AL, BMC Neurosci 2013 14 40 10.1186/1471-2202-14-40 23531041
14. Neuroprotection of midbrain dopaminergic cells in MPTP-treated mice after near-infrared light treatment. Shaw VE, Spana S, Ashkan K, Benabid AL, Stone J, Baker GE, Mitrofanis J, J Comp Neurol 2010 518 25 40 10.1002/cne.22207 19882716
15. Photobiomodulation enhances nigral dopaminergic cell survival in a chronic MPTP mouse model of Parkinson's disease. Peoples C, Spana S, Ashkan K, Benabid AL, Stone J, Baker GE, Mitrofanis J, Parkinsonism Relat Disord 2012 18 469 476 10.1016/j.parkreldis.2012.01.005 22285756
16. Non-invasive infra-red therapy (1072 nm) reduces beta-amyloid protein levels in the brain of an Alzheimer's disease mouse model, TASTPM. Grillo SL, Duggett NA, Ennaceur A, Chazot PL, J Photochem Photobiol B 2013 123 13 22 23603448
17. Transcranial laser therapy attenuates amyloid-beta peptide neuropathology in amyloid-beta protein precursor transgenic mice. De Taboada L, Yu J, El-Amouri S, Gattoni-Celli S, Richieri S, McCarthy T, Streeter J, Kindy MS, J Alzheimers Dis 2011 23 521 535 21116053
18. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1). Lampl Y, Zivin JA, Fisher M, Lew R, Welin L, Dahlof B, Borenstein P, Andersson B, Perez J, Caparo C, Ilic S, Oron U, Stroke 2007 38 1843 1849 10.1161/STROKEAHA.106. 478230 17463313 (Pubitemid 46847257)
19. Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxiety. Schiffer F, Johnston AL, Ravichandran C, Polcari A, Teicher MH, Webb RH, Hamblin MR, Behav Brain Funct 2009 5 46 10.1186/1744-9081-5-46 19995444
20. Long-term safety of low-level laser therapy at different power densities and single or multiple applications to the bone marrow in mice. Tuby H, Hertzberg E, Maltz L, Oron U, Photomed Laser Surg 2013 31 269 273 10.1089/pho.2012.3395 23675984
21. Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia. Ittner LM, Fath T, Ke YD, Bi M, van Eersel J, Li KM, Gunning P, Gotz J, Proc Natl Acad Sci USA 2008 105 15997 16002 10.1073/pnas.0808084105 18832465
22. Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models. van Eersel J, Ke YD, Liu X, Delerue F, Kril JJ, Gotz J, Ittner LM, Proc Natl Acad Sci USA 2010 107 13888 13893 10.1073/pnas.1009038107 20643941
23. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, Copeland NG, Lee MK, Younkin LH, Wagner SL, Younkin SG, Borchelt DR, Hum Mol Genet 2004 13 159 170 14645205 (Pubitemid 38111354)
24. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, Prada C, Greenberg SM, Bacskai BJ, Frosch MP, Neurobiol Dis 2006 24 516 524 10.1016/j.nbd.2006.08.017 17029828 (Pubitemid 44716680)
25. Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. Cao D, Lu H, Lewis TL, Li L, J Biol Chem 2007 282 36275 36282 10.1074/jbc.M703561200 17942401
26. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Truett GE, Heeger P, Mynatt RL, Truett AA, Walker JA, Warman ML, Biotechniques 2000 29 52 54 10907076 (Pubitemid 30439416)
27. The impact of near-infrared light on dopaminergic cell survival in a transgenic mouse model of parkinsonism. Purushothuman S, Nandasena C, Johnstone DM, Stone J, Mitrofanis J, Brain Res 2013 1535C 61 70
28. The response of cerebral cortex to haemorrhagic damage: experimental evidence from a penetrating injury model. Purushothuman S, Marotte L, Stowe S, Johnstone DM, Stone J, PLoS One 2013 8 59740 10.1371/journal.pone.0059740 23555765
29. Quantification of cerebral amyloid angiopathy and parenchymal amyloid plaques with Congo red histochemical stain. Wilcock DM, Gordon MN, Morgan D, Nat Protoc 2006 1 1591 1595 10.1038/nprot.2006.277 17406451
30. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease. Yan Q, Zhang J, Liu H, Babu-Khan S, Vassar R, Biere AL, Citron M, Landreth G, J Neurosci 2003 23 7504 7509 12930788 (Pubitemid 37034066)
31. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Augustinack JC, Schneider A, Mandelkow EM, Hyman BT, Acta Neuropathol 2002 103 26 35 10.1007/s004010100423 11837744 (Pubitemid 36075309)
32. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Bruck W, Bitsch A, Kolenda H, Bruck Y, Stiefel M, Lassmann H, Ann Neurol 1997 42 783 793 10.1002/ana.410420515 9392578 (Pubitemid 27481551)
33. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA, J Neurochem 1997 68 2092 2097 9109537 (Pubitemid 27176147)
34. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Mecocci P, MacGarvey U, Beal MF, Ann Neurol 1994 36 747 751 10.1002/ana.410360510 7979220 (Pubitemid 24337634)
35. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice. Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM, Arancio O, Ann Neurol 2004 55 801 814 10.1002/ana.20101 15174014 (Pubitemid 38702575)
36. Low-level laser therapy applied transcranially to rats after induction of stroke significantly reduces long-term neurological deficits. Oron A, Oron U, Chen J, Eilam A, Zhang C, Sadeh M, Lampl Y, Streeter J, DeTaboada L, Chopp M, Stroke 2006 37 2620 2624 10.1161/01.STR.0000242775.14642.b8 16946145 (Pubitemid 44454688)
37. Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice. Blanchard V, Moussaoui S, Czech C, Touchet N, Bonici B, Planche M, Canton T, Jedidi I, Gohin M, Wirths O, Bayer TA, Langui D, Duyckaerts C, Tremp G, Pradier L, Exp Neurol 2003 184 247 263 10.1016/S0014-4886(03)00252-8 14637096 (Pubitemid 37444035)
38. Mitochondrial mechanisms of photobiomodulation in context of new data about multiple roles of ATP. Karu T, Photomed Laser Surg 2010 28 159 160 10.1089/pho.2010.2789 20374017
39. Import of radiation phenomena of electrons and therapeutic low-level laser in regard to the mitochondrial energy transfer. Wilden L, Karthein R, J Clin Laser Med Surg 1998 16 159 165 9743654 (Pubitemid 28345892)
40. Light-emitting diode treatment reverses the effect of TTX on cytochrome oxidase in neurons. Wong-Riley MT, Bai X, Buchmann E, Whelan HT, Neuroreport 2001 12 3033 3037 10.1097/00001756-200110080-00011 11568632 (Pubitemid 32907000)
41. In vitro effects of low-level laser irradiation for bone marrow mesenchymal stem cells: proliferation, growth factors secretion and myogenic differentiation. Hou JF, Zhang H, Yuan X, Li J, Wei YJ, Hu SS, Lasers Surg Med 2008 40 726 733 10.1002/lsm.20709 19065562
42. Modulations of VEGF and iNOS in the rat heart by low level laser therapy are associated with cardioprotection and enhanced angiogenesis. Tuby H, Maltz L, Oron U, Lasers Surg Med 2006 38 682 688 10.1002/lsm.20377 16800001 (Pubitemid 44300942)
43. Induction of autologous mesenchymal stem cells in the bone marrow by low-level laser therapy has profound beneficial effects on the infarcted rat heart. Tuby H, Maltz L, Oron U, Lasers Surg Med 2011 43 401 409 10.1002/lsm.21063 21674545
44. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM, J Cell Biol 2002 156 1051 1063 10.1083/jcb.200108057 11901170 (Pubitemid 34839854)
45. The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease. Aliev G, Smith MA, Seyidov D, Neal ML, Lamb BT, Nunomura A, Gasimov EK, Vinters HV, Perry G, LaManna JC, Friedland RP, Brain Pathol 2002 12 21 35 11770899 (Pubitemid 33131359)
46. Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease. Hamel E, Nicolakakis N, Aboulkassim T, Ongali B, Tong XK, Exp Physiol 2008 93 116 120 17911359 (Pubitemid 350293970)
47. Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease. Zhu X, Perry G, Moreira PI, Aliev G, Cash AD, Hirai K, Smith MA, J Alzheimers Dis 2006 9 147 153 16873962 (Pubitemid 44078642)
48. Pathological role of hypoxia in Alzheimer's disease. Zhang X, Le W, Exp Neurol 2010 223 299 303 10.1016/j.expneurol.2009.07.033 19679125
49. Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like tauopathy in female rats. Wen Y, Yang S, Liu R, Brun-Zinkernagel AM, Koulen P, Simpkins JW, J Biol Chem 2004 279 22684 22692 10.1074/jbc.M311768200 14982935 (Pubitemid 38679469)
50. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Uttara B, Singh AV, Zamboni P, Mahajan RT, Curr Neuropharmacol 2009 7 65 74 10.2174/157015909787602823 19721819